WHO should buy diabetes drugs in bulk for poor nations, Novo Nordisk says (Bloomberg, 7 September 2011)

07 Sept 2011


Lars Rebien Soerensen, Chief Executive Officer of Novo Nordisk A/S, suggests a strategy to tackle diabetes in developing countries.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story